NEURONES (NRO.PA) Stock Cash Flow
Europe - EPA:NRO - FR0004050250 - Common Stock
38.55 EUR
-0.25 (-0.64%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 63.23M | 63.23M | 58.58M | 51.77M | 42.94M | |||
| Depreciation Amortization | 17.66M | 17.66M | 16.76M | 16.57M | 14.68M | |||
| Change In Working Capital | 8.67M | 8.67M | -1.58M | -16.10M | 5.00M | |||
| Taxes Paid | 24.81M | 24.81M | 25.35M | 24.13M | 16.16M | |||
| Other non cash items | -5.17M | -5.17M | -1.68M | 2.72M | 1.88M | |||
| OPERATING CASH FLOW | 84.38M | 84.38M | 72.08M | 54.97M | 64.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -12.04M | -12.04M | -17.98M | -10.61M | -6.58M | |||
| Other Investing Activity | -7.65M | -7.65M | -3.59M | -1.65M | -4.04M | |||
| INVESTING CASH FLOW | -19.69M | -19.69M | -21.57M | -12.26M | -10.62M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -7.33M | -7.33M | -3.59M | -7.07M | -6.61M | |||
| Stock Issued/Repurchased | N/A | -28.00K | 57.00K | -107.00K | 89.00K | |||
| Dividend Paid | -29.13M | -29.13M | -26.65M | -24.22M | -48.42M | |||
| Other Financing Activity | 2.01M | 2.01M | 3.12M | -4.67M | -486.00K | |||
| FINANCING CASH FLOW | -34.48M | -34.48M | -27.06M | -36.08M | -55.42M | |||
| Exchange Rate Effect | 357.00K | 357.00K | 34.00K | 252.00K | 130.00K | |||
| CHANGE IN CASH | 30.57M | 30.57M | 23.48M | 6.89M | -1.42M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 84.38M | 84.38M | 72.08M | 54.97M | 64.50M | |||
| Capital Expenditure | -12.04M | -12.04M | -17.98M | -10.61M | -6.58M | |||
| FREE CASH FLOW | 72.34M | 72.34M | 54.09M | 44.36M | 57.92M | |||
All data in EUR